Bilaxten 20 mg (Bilastine)

Bilaxten is a commercial brand of Bilastine, an oral antihistamine used for the treatment of allergic rhinoconjunctivitis and urticaria. The drug was originally researched and developed by the Spanish pharmaceutical company Faes Farma. This specific molecule, bilastine, represents one of the most significant successes for Spanish pharmaceutical R&D, having been licensed for commercialization in over 100 countries under various trade names.

Manufacturing primarily takes place at Faes Farma's industrial facilities in Spain, specifically in Leioa (Vizcaya), although global distribution may involve secondary packaging or production sites in other regions. Faes Farma remains an independent Spanish company listed on the Madrid Stock Exchange, maintaining ultimate ownership and control over its flagship allergy therapeutic. The brand is synonymous with modern Spanish biopharmaceutical innovation.